Otsuka Pharmaceutical Co., Ltd. et al v. Unichem Laboratories Ltd. > Summary
Court Case Number 1:20-cv-01295
Filing Date Sep 25, 2020
Termination Date Oct 20, 2021
Court Delaware District Court
Status Dismissed - Settled
JudgesLeonard P. Stark
Defendant
Plaintiff Attorneys
12Otsuka Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Denise Main
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Erin McGeehan Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Tyler B. Latcham
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Steven J. Balick
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Tyler B. Latcham
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Denise Main
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Andrew C. Mayo
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Erin McGeehan Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
Attorney Name: Collette Corser
Defendant Attorneys
Counter Defendant
4H. Lundbeck A/S
Attorney Name: Steven J. Balick
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Counter Claimant
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
RE048059 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Jun 23, 2020 |
07888362 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Feb 15, 2011 |